LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.10
+0.01 (0.16%)
Apr 28, 2025, 4:00 PM EDT - Market closed
LifeMD Market Cap
LifeMD has a market cap or net worth of $271.96 million as of April 28, 2025. Its market cap has decreased by -31.67% in one year.
Market Cap
271.96M
Enterprise Value
262.06M
1-Year Change
-31.67%
Ranking
Category
Stock Price
$6.10
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $271.96M, an increase of 7,670.30%. That is a compound annual growth rate of 43.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 271.50M | 26.63% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |